Fentanyl and Hydroxyurea drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fentanyl (fentanyl citrate) and Hydroxyurea (hydroxyurea). Common drug interactions include paraneoplastic syndrome among females and dehydration among males.

The phase IV clinical study analyzes what interactions people have when they take Fentanyl and Hydroxyurea. It is created by eHealthMe based on reports of 66 people who take the same drugs from the FDA, and is updated regularly.

What is Fentanyl?

Fentanyl has active ingredients of fentanyl citrate. It is often used in pain. eHealthMe is studying from 73,301 Fentanyl users. Check the latest studies of Fentanyl.

What is Hydroxyurea?

Hydroxyurea has active ingredients of hydroxyurea. It is often used in polycythemia vera. eHealthMe is studying from 17,240 Hydroxyurea users. Check the latest studies of Hydroxyurea.



On Jul, 14, 2026

66 people who take Fentanyl and Hydroxyurea together, and have interactions are studied.

Fentanyl and Hydroxyurea drug interactions.

What are the common drug interactions of Fentanyl and Hydroxyurea, by gender? *:

female:

  1. Paraneoplastic syndrome (symptom that is the consequence of the presence of cancer in the body)
  2. Abasia (inability to walk)
  3. Abdominal pain
  4. Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
  5. Asthenia (weakness)
  6. Drug ineffective
  7. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  8. Haematemesis (vomiting of blood)
  9. Headache (pain in head)
  10. Hypotension (abnormally low blood pressure)

male:

  1. Dehydration (dryness resulting from the removal of water)
  2. Nausea (feeling of having an urge to vomit)
  3. Pain in extremity
  4. Sepsis (a severe blood infection that can lead to organ failure and death)
  5. Blood creatinine increased
  6. Death
  7. Lethargy (tiredness)
  8. Abdominal distension
  9. Acute lymphocytic leukaemia recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent)
  10. Aspergillus test positive

What are the common drug interactions of Fentanyl and Hydroxyurea, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Cough
  2. Pyrexia (fever)
  3. Paraneoplastic syndrome (symptom that is the consequence of the presence of cancer in the body)
  4. Abdominal distension
  5. Acute lymphocytic leukaemia recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent)
  6. Aspergillus test positive
  7. Bacteraemia (presence of bacteria in the blood)
  8. Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain)
  9. C-reactive protein increased
  10. Central nervous system lesion (an abnormality in tissue of brain or spinal cord)

20-29:

  1. Haemoglobin decreased
  2. White blood cell count increased
  3. Anaemia (lack of blood)
  4. Asthenia (weakness)
  5. Dizziness
  6. Haematocrit decreased
  7. Lymphocyte count decreased
  8. Mean cell volume decreased (less of the average red blood cell volume)
  9. Monocyte count increased
  10. Nausea (feeling of having an urge to vomit)

30-39:

  1. Anaemia (lack of blood)
  2. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  3. Splenic infarction (tissue damage of spleen)
  4. Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)
  5. Abdominal pain
  6. Drug ineffective
  7. Nausea (feeling of having an urge to vomit)
  8. Sepsis (a severe blood infection that can lead to organ failure and death)
  9. Vomiting

40-49:

  1. Convulsions (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled of muscles contract and relax rapidly and repeatedly)
  2. Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
  3. Acute myeloid leukaemia recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent)
  4. Application site rash
  5. Coma (state of unconsciousness lasting more than six hours)
  6. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
  7. Grunting (abnormal, short, deep, hoarse sounds in exhalation that often accompany severe chest pain)
  8. Neoplasm progression (growth of tumour)
  9. Pneumonia klebsiella (pneumonia caused by bacteria klebsiella)
  10. Rash macular (small, flat red spots)

50-59:

  1. Abdominal pain upper
  2. Bladder cyst
  3. Blood urine present
  4. Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain)
  5. Cardiac arrest
  6. Chest discomfort
  7. Deafness bilateral
  8. Death
  9. Depressed level of consciousness
  10. Depression

60+:

  1. Arthralgia (joint pain)
  2. Pain in extremity
  3. Diarrhoea
  4. General physical health deterioration (weak health status)
  5. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  6. Vomiting
  7. Dehydration (dryness resulting from the removal of water)
  8. Abasia (inability to walk)
  9. Abdominal pain
  10. Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)

What are the existing conditions these people have? *

  1. Nausea (feeling of having an urge to vomit): 9 people, 13.64%
  2. Constipation: 9 people, 13.64%
  3. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 8 people, 12.12%
  4. Headache (pain in head): 7 people, 10.61%
  5. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 7 people, 10.61%
  6. Squamous Cell Carcinoma (a cancer of a kind of epithelial cell): 6 people, 9.09%
  7. Nausea And Vomiting: 6 people, 9.09%
  8. Hypersensitivity: 6 people, 9.09%
  9. Primary Myelofibrosis (primary disorder of the bone marrow): 5 people, 7.58%
  10. Insomnia (sleeplessness): 5 people, 7.58%

* Approximation only. Some reports may have incomplete information.

Do you take Fentanyl and Hydroxyurea?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Fentanyl and Hydroxyurea:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Fentanyl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Hydroxyurea:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fentanyl and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hydroxyurea and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on fentanyl citrate and hydroxyurea (the active ingredients of Fentanyl and Hydroxyurea, respectively), and Fentanyl and Hydroxyurea (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: